|
Volume 8, Review 60 |
September 1998 |
|
J. Bousquet |
|
Chairman's introduction |
|
S-E. Dahlen |
|
Leukotrienes as common mediators of airway obstruction evoked by many trigger factors in asthma |
|
W.J. Calhoun |
|
The impact of antileukotriene therapy on markers of airway inflammation |
|
S.E. Wenzel |
|
Clinical effects of antileukotriene therapy |
|
N.C. Barnes |
|
The place of antileukotriene therapy in asthma management guidelines |
|
J. Bousquet |
|
Chairman's summary |
|
388 |
Panel discussion |